Global Contraceptive Drugs And Devices Market Size By Type, By Distribution Channel, By Geographic Scope And Forecast
Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
Contraceptive Drugs And Devices Market Size And Forecast
Contraceptive Drugs And Devices Market size was valued at USD 21.8 Billion in 2023 and is projected to reach USD 39.9 Billion by 2030, growing at a CAGR of 6.1% during the forecast period 2024-2030.
Global Contraceptive Drugs And Devices Market Drivers
The market drivers for the Contraceptive Drugs And Devices Market can be influenced by various factors. These may include
Raising Knowledge and Consciousness Growing awareness of family planning and the importance of contraceptives in preventing unwanted pregnancies is an important factor. Education campaigns and activities help people become more aware of the various forms of contraception that are available.
Growing World Population The need for efficient contraceptive methods has increased due to the world’s population growth. Family planning is being promoted by governments and healthcare institutions to address population-related issues, which is driving up market prices.
Technological Progress The creation of novel drug formulations and cutting-edge contraceptive devices, among other ongoing developments in contraceptive technologies, propels market expansion. The goals of these developments are to improve user ease, safety, and efficacy.
Increasing the Number of Women in the Workforce There is now more focus on family planning as a result of the increase in female employment. With the use of contraceptives, women can plan and manage their reproductive choices, advancing their professional and personal objectives.
Governmental Proposals and Assistance Initiatives, regulations, and programs spearheaded by the government that support family planning and make contraceptives accessible are essential. Growth in the market is facilitated by awareness campaigns, subsidies, and better healthcare infrastructure.
Shifting Attitudes and Lifestyles The need for contraceptives is influenced by shifting social attitudes toward family planning and altering lifestyles, such as delaying marriage and having children. More and more people are looking for reversible and long-term contraceptive options.
Increasing Costs of Healthcare Globally increasing healthcare spending helps to make contraceptive treatments and products more accessible. An increasing number of people have access to a range of contraception choices as the healthcare system advances.
High Rate of Unintentional Pregnancy Effective contraceptive methods are in high demand due to the persistent worry over the occurrence of unwanted pregnancies. A way to address this problem and lower the number of unintended pregnancies is through contraceptive medications and technologies.
Increasing Channels of Distribution Improved distribution networks, such as internet sites and physical stores, increase the accessibility of contraceptives to a larger audience. Adoption rates rise in response to improved availability.
Changes in Cultural Norms The market is impacted by shifting cultural norms and views on family planning and reproductive health. The acceptance and use of contraceptives tend to rise when societies become more comfortable talking about these issues.
Global Contraceptive Drugs And Devices Market Restraints
Several factors can act as restraints or challenges for the Contraceptive Drugs And Devices Market. These may include
Raising Knowledge and Consciousness Growing awareness of family planning and the importance of contraceptives in preventing unwanted pregnancies is an important factor. Education campaigns and activities help people become more aware of the various forms of contraception that are available.
Growing World Population The need for efficient contraceptive methods has increased due to the world’s population growth. Family planning is being promoted by governments and healthcare institutions to address population-related issues, which is driving up market prices.
Technological Progress The creation of novel drug formulations and cutting-edge contraceptive devices, among other ongoing developments in contraceptive technologies, propels market expansion. The goals of these developments are to improve user ease, safety, and efficacy.
Increasing the Number of Women in the Workforce There is now more focus on family planning as a result of the increase in female employment. With the use of contraceptives, women can plan and manage their reproductive choices, advancing their professional and personal objectives.
Governmental Proposals and Assistance Initiatives, regulations, and programs spearheaded by the government that support family planning and make contraceptives accessible are essential. Growth in the market is facilitated by awareness campaigns, subsidies, and better healthcare infrastructure.
Shifting Attitudes and Lifestyles The need for contraceptives is influenced by shifting social attitudes toward family planning and altering lifestyles, such as delaying marriage and having children. More and more people are looking for reversible and long-term contraceptive options.
Increasing Costs of Healthcare Globally increasing healthcare spending helps to make contraceptive treatments and products more accessible. An increasing number of people have access to a range of contraception choices as the healthcare system advances.
High Rate of Unintentional Pregnancy Effective contraceptive methods are in high demand due to the persistent worry over the occurrence of unwanted pregnancies. A way to address this problem and lower the number of unintended pregnancies is through contraceptive medications and technologies.
Increasing Channels of Distribution Improved distribution networks, such as internet sites and physical stores, increase the accessibility of contraceptives to a larger audience. Adoption rates rise in response to improved availability.
Changes in Cultural Norms The market is impacted by shifting cultural norms and views on family planning and reproductive health. The acceptance and use of contraceptives tend to rise when societies become more comfortable talking about these issues.
Global Contraceptive Drugs And Devices Market Segmentation Analysis
The Global Contraceptive Drugs And Devices Market is Segmented on the basis of Type, Distribution Channel, and Geography.
Contraceptive Drugs And Devices Market, By Type
Oral Contraceptive Pills (OCPs) The most popular form of birth control is oral contraceptive pills (OCPs), which contain hormones that block ovulation and conception.
Intrauterine Contraceptives Hormone injections with a long half-life that work as effective contraception for several months.
Implants Long-acting, subcutaneous hormonal devices placed beneath the skin that release hormones to stop conception.
Contraceptive Drugs And Devices Market, By Distribution Channel
Hospitals and Clinics Prescriptions from medical practitioners are required for access.
Pharmacies Condoms and ECPs are among the contraceptives that are available over the counter.
Online Retailers Online retailers are becoming a more and more popular option for discreet and easy contraceptive purchases.
Family Planning Organizations Nonprofits that offer information and access to contraception.
Contraceptive Drugs And Devices Market, By Geography
North America Market conditions and demand in the United States, Canada, and Mexico.
Europe Analysis of the Contraceptive Drugs And Devices Market in European Countries.
Asia-Pacific Focusing on countries like China, India, Japan, South Korea, and others.
Middle East and Africa Examining market dynamics in the Middle East and African regions.
Latin America Covering market trends and developments in countries across Latin America.
Key Players
The major players in the Contraceptive Drugs And Devices Market are
Bayer AG
Pfizer Inc.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Allergan plc
Church & Dwight Co., Inc.
CooperSurgical, Inc.
The Female Health Company (FC2)
Mylan N.V.
Johnson & Johnson
Report Scope
REPORT ATTRIBUTES
DETAILS
STUDY PERIOD
2020-2030
BASE YEAR
2023
FORECAST PERIOD
2024-2030
HISTORICAL PERIOD
2020-2022
UNIT
Value (USD Billion)
KEY COMPANIES PROFILED
Bayer AG, Pfizer Inc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Allergan plc, Church & Dwight C
SEGMENTS COVERED
By Type
By Distribution Channel
By Geography
CUSTOMIZATION SCOPE
Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope
Top Trending Reports
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
We take a deep dive into the market, looking at both the numbers (quantitative) and the more nuanced stuff (qualitative) by breaking it down into segments based on things like money and other factors. We'll give you the (in USD Billion) for each piece of the puzzle. You'll see which region and segment are expected to be the fastest growing and biggest players. Plus, we'll analyze each region to see how much of the product/service they're using and what's impacting the market there. We'll also cover the competition, including rankings of the big names, new stuff they're launching, who's partnering with who, and who's buying who in the last five years. Get ready for detailed company profiles with overviews, insights, product comparisons, and even a SWOT analysis for the major players. We'll give you the current and future outlook, highlighting growth opportunities, what's driving things forward, and the challenges and roadblocks in both new and established markets. We'll even use Porter's five forces to really dig into the market from all angles. You'll get a clear understanding of the market's value chain, the at play, and where the growth opportunities are headed. Oh, and we'll throw in 6 months of analyst support after you get the report.
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.
For a single, multi and corporate client license, the report will be available in PDF format.
Sample report would be given you in excel format. For more questions please contact:
